| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967355 | Vaccine | 2012 | 5 Pages |
Abstract
⺠The cost-effectiveness of extended pertussis booster programs was estimated. ⺠An age structured transmission dynamic model was used. ⺠A booster dose at 12 years can be considered as cost effective (â¬4200/QALY). ⺠Other considered booster strategies could also be labeled as cost-effective. ⺠The impact of assumptions regarding disease related parameters was limited.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mark H. Rozenbaum, Elisabetta De Cao, Maarten J. Postma,